Clinical symptoms and 'off-label' prescribing in children with asthma

British Journal of General Practice

Volumn 57, Issue 536, 2007, Pages 220-222

  McCowan, Colin ^a   Hoskins, Gaylor ^a   Neville, Ron G ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Asthma; Child health; Drug labeling; Family practice; Prescriptions

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CONSULTATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OFF LABEL DRUG USE; PATIENT COMPLIANCE; PRESCRIPTION; PRIMARY MEDICAL CARE; RECOMMENDED DRUG DOSE; SELF REPORT; SYMPTOM; UNITED KINGDOM;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG LABELING; FAMILY PRACTICE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICAL AUDIT; PHYSICIAN'S PRACTICE PATTERNS; TREATMENT OUTCOME;

EID: 33847682875     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. ISAAC: The International Study of Asthma and Allergies Steering Committee. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12(2): 315-335.
2. Scottish Intercollegiate Guideline Network Guidelines and the British Thoracic Society. Guideline on the management of asthma. Edinburgh: Scottish Intercollegiate Guideline Network, 2003.
3. Ufer M, Kane A, Karlsson A, et al. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm. Eur J Clin Pharmacol 2003; 58(11): 779-783.
4. Hill P. Off licence and off label prescribing in children: litigation fears for physicians. Arch Dis Child 2005; 90(Suppl 1): i17-18.
5. Neville RG, Hoskins G, Smith B, et al. The economic and human costs of asthma in Scotland. Prim Care Resp J 2003; 12(4): 115-118.
6. Department of Health. National Service Framework for Children, young people and maternity services. Department of Health: London, 2004. http://www.dh.gov.uk/PublicationsAndStatistics/ Publications/ PublicationsPolicyAndGuidance/PublicationsPolicyAnd GuidanceArticle/fs/ en?CONTENT_ID=4089100&chk=Egpznc (accessed 6 Feb 2007).
7. Ekins-Daukes S, Helms PJ, Simpson CR, et al. Off-label prescribing to children in primary care: retrospective observational study. Eur J Clin Pharmacol 2004; 60(5): 349-353.
8. Bucheler R, Schwab M, Mörike K, et al. Off label prescribing to children in primary care in Germany: retrospective cohort study. BMJ 2002; 324(7349): 1311-1312.
9. Te Jong G, Eland IA, Sturkenboom MCJM, et al. Unlicensed and off label prescription of drugs to children: population based cohort study. BMJ 2002; 324(7349): 1313-1314.
10. Schirm E, Tobi H, de Jong-van den Berg LT. Unlicensed and off label drug use by children in the community: cross sectional study. BMJ 2002; (324)7349: 1312-1313.
11. McCowan C, Neville RG, and Hoskins G. An academic, pharmaceutical and practice collaboration to implement asthma guidelines. Prim Care Respir J 2005; 14(2): 106-111.